echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Obes Surg: Associated with less weight loss after bariatric surgery in people with type 2 diabetes

    Obes Surg: Associated with less weight loss after bariatric surgery in people with type 2 diabetes

    • Last Update: 2022-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Background: Bariatric surgery is the most effective treatment to achieve significant and sustained weight loss, consistently inducing long-term remission
    of the disease in patients affected by type 2 diabetes mellitus (T2D).
    Several changes have occurred after bariatric surgery, such as increased GLP-1 secretion, marked inhibition of plasma branched-chain amino acids, increased circulating bile acids, and changes in the gut microbiota, which are all thought to contribute to good metabolic outcomes
    Recently, however, in an excellent study by Yoshino and colleagues, matched weight loss induced by gastric bypass (RYGB) or diet alone affected a variety of metabolic outcomes, such as liver, muscle, and adipose tissue insulin sensitivity; β cell function; Metabolic reactions to mixed meals; and assess 24-hour plasma glucose, insulin, and free fatty acid profiles
    They found that diet and RYGB produced similar metabolic benefits on the main physiological factors that regulate glycemic control, suggesting that the beneficial metabolic effects of bariatric surgery can be attributed solely to weight loss itself and not to any effects
    unrelated to weight loss.
    Since lifestyle interventions are often unsuccessful for long-term weight loss, the clinical utility of bariatric surgery is unquestionable

    It is now well established that the mechanisms leading to weight loss after bariatric surgery cannot be fully attributed to a decrease in nutrient intake and mild absorption of
    A number of other mechanisms are also involved, which include increased secretion of enterogenic sex hormones, having anorexia, changing dietary patterns, bile acids and microbiota adaptation
    However, even after bariatric surgery, some patients only lose a small amount of excess weight, which represents treatment failure
    Therefore, identifying predictors of outcome after bariatric surgery may help identify ideal candidates for this intervention, but may also help set realistic goals
    for weight loss outcomes.

    Several studies now assess the preoperative determinants
    of weight loss after bariatric surgery.
    Among them, age and preoperative body mass index are well-known predictors of subsequent weight loss
    Postprandial hypoglycemia is a common complication after bariatric surgery, and in a recent study, we found that after bariatric surgery, the occurrence of postprandial hypoglycemia is associated
    with weight loss after bariatric surgery.
    Although other studies have failed to replicate the independent effects of T2D on weight loss after bariatric surgery, comorbidities present prior to the intervention, including the presence of T2D, have been reported to be risk factors
    for worse outcomes after bariatric surgery.

    Objective: To assess whether the presence of type 2 diabetes mellitus (T2D) at baseline and remission of T2D after bariatric surgery affected the outcome of
    weight loss.

    Methods: The data of 312 morbidly obese patients who underwent continuous bariatric surgery were analyzed
    Patients who underwent RYGB (77%) or sleeve gastrectomy (23%) had their weight followed for 1, 2, 3, 4, and 5 years at regular outpatient follow-up (N = 269, 312, 210, 151, 105 per year, respectively).

    Assess T2D mitigation according to ADA criteria

    Results: Across the dataset, 92 patients were affected
    by T2D.
    Patients with T2D were older than those without T2D (52±9 years versus 45±11 years, p < 0.
    0001), but there were no differences
    in baseline body mass index, sex, and type of intervention received 。 We found that the presence of baseline T2D was associated with smaller weight loss at 1, 2, 3, 4, and 5 years after bariatric surgery (δ body mass index at 2 years: 13.
    7 [7.
    7]vs 16.
    4 [7.
    3] kg/m2; At 5 years, patients with T2D disease and non-T2D disease were 12.
    9 [8.
    8] and 16.
    3 [8.
    7] kg/m2, respectively, and both < 0.

    When patients with T2D were classified as remitters and non-remitters, the weight loss of non-remitters was significantly smaller than that of remitters (δ body mass index at 2 years: 11.
    8 [6.
    3] vs 15.
    4 [7.
    8] kg/m2; After 5 years: 8.
    0 [7.
    1] vs 15.
    0 [7.
    2] kg/m2, non-sender vs.
    sender, p < 0.

    1 In the pooled data, age, baseline body mass index (A) and age (B) were associated
    with δ body mass index follow-up at 2 years.
    Data is displayed as RYGB (black circle) or LSG (gray circle)

    Table 1 Correlation coefficients for age and baseline BMI effects, or 95% confidence intervals for RYGB effects, T2D loss, and T2D remission at 1, 2, 3, 4, and 5 years of follow-up

    2 The histogram shows the average δ body mass index (A)
    at 2 years of follow-up of T2D and non-T2D patients.
    The histogram shows the mean δ body mass index (B)
    of T2D patients in remission and non-remission at 2 years of follow-up.
    Baseline glycosylated hemoglobin was negatively associated with δ body mass index at 2 years follow-up, but this association was mainly driven by non-emitters (C); * p < 0.

    Table 2 Weight loss results
    in three groups.

    Figure 3 Body mass index progression
    from baseline to multi-year follow-up.
    The black line represents non-remitters, the gray line represents remitters, and the dotted line represents patients
    without T2D.
    #p < 0.
    05 between remitters and patients without T2D < 0.
    05, * between non-remitters and patients without T2D p < 0.

    Conclusions: T2D was associated with less weight loss after bariatric surgery, especially in
    subjects who did not achieve diabetic remission.

    Original source:

    Rebelos E, Moriconi D, Honka MJ,et al.
    Decreased Weight Loss Following Bariatric Surgery in Patients with Type 2 Diabetes.
    Obes Surg 2022 Nov 02

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.